Hashitoxicosis with pericardial effusion

Lamari, Annalisa; Dattilo, Giuseppe; Tulino, Domenico; Marte, Filippo; Patanè, Salvatore

doi:10.1016/j.ijcard.2009.03.131

Cited by 8 publications

(8 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…with pericardial effusion" [1] regarding "Hashitoxicosis with pericardial effusion" [2]. We can say that his interpretation coincides with our interpretation and with the knowledge about Hashitoxicosis and Graves' disease.…”

Section: Graves' Disease Hashitoxicosis Pericardial Effusion Thyrotoxsupporting

confidence: 80%

“…Most subjects with DMD die by the end of their third decade of life because of respiratory or heart failure. Management of respiratory failure by non-invasive positive pressure ventilation has been shown to improve gas exchange and survival in subjects with DMD [1,2]. On the other hand, almost all of them exhibit left ventricular (LV) systolic dysfunction similar to that in subjects with idiopathic dilated cardiomyopathy.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Definitive diagnosis of Hashitoxicosis with pericardial effusion

Lamari

Dattilo

Tulino

et al. 2010

International Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

Section: Graves' Disease Hashitoxicosis Pericardial Effusion Thyrotoxsupporting

confidence: 80%

mentioning

confidence: 99%

Definitive diagnosis of Hashitoxicosis with pericardial effusion

Lamari

Dattilo

Tulino

et al. 2010

International Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

“…Thus when it comes to the case described by Lamari et al [1], in my opinion it is not possible to make the differential diagnosis between Hashitoxicosis and Graves' disease with the given data. In fact, positive TSH-R Abs highly suggest Graves' disease in a thyrotoxic patient even if it is subclinical [3,6].…”

Section: Dear Editormentioning

confidence: 80%

“…I have read with interest the letter to the Editor entitled "Hashitoxicosis with pericardial effusion" which was published online in April 2009 in the International Journal of Cardiology [1]. I would like to make a few comments regarding the diagnosis of Hashitoxicosis in this patient.…”

Section: Dear Editormentioning

confidence: 96%

Hashitoxicosis (or Graves' disease?) with pericardial effusion

Çakır

2010

International Journal of Cardiology

View full text Add to dashboard Cite

“… 16 , 17 Pericardial effusion may be a very rare complication of other causes of thyrotoxicosis, as hashitoxicosis or toxic multinodular goiter. 18 , 19…”

Section: Discussionmentioning

confidence: 99%

Somatostatin Analogue Treatment of a TSH-Secreting Adenoma Presenting With Accelerated Bone Metabolism and a Pericardial Effusion

Mousiolis

Rapti²,

Grammatiki

et al. 2016

Medicine

View full text Add to dashboard Cite

Increased bone turnover and other less frequent comorbidities of hyperthyroidism, such as heart failure, have only rarely been reported in association with central hyperthyroidism due to a thyrotropin (TSH)-secreting pituitary adenoma (TSHoma). Treatment is highly empirical and relies on eliminating the tumor and the hyperthyroid state.We report here an unusual case of a 39-year-old man who was initially admitted for management of pleuritic chest pain and fever of unknown origin. Diagnostic work up confirmed pericarditis and pleural effusion both refractory to treatment. The patient had a previous history of persistently elevated levels of alkaline phosphatase (ALP), indicative of increased bone turnover. He had also initially been treated with thyroxine supplementation due to elevated TSH levels. During the diagnostic process a TSHoma was revealed. Thyroxine was discontinued, and resection of the pituitary tumor followed by treatment with a somatostatin analog led to complete recession of the effusions, normalization of ALP, and shrinkage of pituitary tumor.Accelerated bone metabolism and pericardial and pleural effusions attributed to a TSHoma may resolve after successful treatment of the tumor. The unexpected clinical course of this case highlights the need for careful long-term surveillance in patients with these rare pituitary adenomas.

show abstract

Hashitoxicosis with pericardial effusion

Cited by 8 publications

References 29 publications

Definitive diagnosis of Hashitoxicosis with pericardial effusion

Definitive diagnosis of Hashitoxicosis with pericardial effusion

Hashitoxicosis (or Graves' disease?) with pericardial effusion

Somatostatin Analogue Treatment of a TSH-Secreting Adenoma Presenting With Accelerated Bone Metabolism and a Pericardial Effusion

Contact Info

Product

Resources

About